Published in
Taylor and Francis Group, Expert Opinion on Drug Metabolism and Toxicology, 1(16), p. 45-57, 2019
DOI: 10.1080/17425255.2020.1702022
Links
Tools
Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations
Journal article published in 2019 by
Rianne A. Weersink 
,
David M. Burger,
Kelly L. Hayward,
Katja Taxis,
Joost P. H. Drenth,
Sander D. Borgsteede
,
David M. Burger,
Kelly L. Hayward,
Katja Taxis,
Joost P. H. Drenth,
Sander D. Borgsteede
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 